Status:
COMPLETED
Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants
Lead Sponsor:
Fox Chase Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-74 years
Phase:
NA
Brief Summary
RATIONALE: Evaluating the knowledge and attitudes of healthy participants toward a new diet and gene test for colorectal cancer risk may help doctors improve acceptance of colorectal cancer screening....
Detailed Description
OBJECTIVES: Part 1 * Determine the willingness of healthy participants to enroll in a genetic and environmental risk assessment for colorectal cancer. * Determine the impact of decision counseling o...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Healthy participants
- Eligible for colorectal cancer screening
- No personal or family history of colorectal cancer
- No more than 1 first-degree relative who has had colorectal cancer
- Part 1:
- Has not undergone regular screening for colorectal cancer
- Part 2:
- Not currently undergoing regular colon cancer testing, including any of the following:
- Fecal occult blood testing within the past year
- Flexible sigmoidoscopy or colonoscopy within the past 5 years
- PATIENT CHARACTERISTICS:
- Age
- 50 to 74
- Performance status
- Not specified
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- Other
- No inflammatory bowel disease (part 1 only)
- No concurrent health issues that would preclude study participation (part 1 only)
- No history of cancer except basal cell or squamous cell skin cancer (part 2 only)
- Able to speak and read English (part 2 only)
- PRIOR CONCURRENT THERAPY:
- Biologic therapy
- Not specified
- Chemotherapy
- Not specified
- Endocrine therapy
- Not specified
- Radiotherapy
- Not specified
- Surgery
- Not specified
Exclusion
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00087360
Start Date
November 1 2003
End Date
May 1 2007
Last Update
July 11 2013
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Bethesda, Maryland, United States, 20892-1182
2
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States, 19107-5541
3
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111
4
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
Nashville, Tennessee, United States, 37232-0165